In general, disclosed herein are
lysyl oxidase (LOX) family inhibitors of Formula (A): or a pharmaceutically acceptable salt thereof. Additionally, disclosed herein are methods directed to treating a
disease of condition associated with the modulation or inhibition of
lysyl oxidase (LOX).